Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Sleep Disorders

Free Subscription Articles published in Chest Retrieve available abstracts of 56 articles: HTML format

Single Articles

April 2025
1. TAMISIER R, Philippe C, Prigent A, Charley-Monaca C, et al
   Change in Sleep Quality Associated With Adaptive Servoventilation for Central Sleep Apnea: Six-Month Follow-Up of the Multicenter Nationwide French "Etude de Cohorte Observationnelle Multicentrique Francaise de Patients Ayant un Syndrome d'Apnees du S
   Chest. 2025;167:1204-1217.
   PubMed     Abstract available
   
   
   
2. HOZUMI H, Endo Y, Kono M, Hasegawa H, et al
   Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis.
   Chest. 2025;167:1107-1119.
   PubMed     Abstract available
   
   
   March 2025
3. VAN DONGEN HPA, Leary EB, Drake C, Bogan R, et al
   Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the
   Chest. 2025;167:863-875.
   PubMed     Abstract available
   
   
   February 2025
4. XAVIER JLA, Fernandes MD, Andrade RGS, Genta PR, et al
   Impact of Exclusive Mouth Route and Lateral Position on the Efficacy of Oronasal CPAP to Treat OSA in Patients With OSA Adapted to Oronasal Mask.
   Chest. 2025;167:611-618.
   PubMed     Abstract available
   
   
   January 2025
5. NOWALK NC, Mokhlesi B, Neborak JM, Masa Jimenez JF, et al
   Gender Differences in Outcomes of Ambulatory and Hospitalized Patients With Obesity Hypoventilation Syndrome.
   Chest. 2025;167:245-258.
   PubMed     Abstract available
   
   
   November 2024
6. AZZOPARDI M, Parsons R, Cadby G, King S, et al
   Identifying Risk of Postoperative Cardiorespiratory Complications in OSA.
   Chest. 2024;166:1197-1208.
   PubMed     Abstract available
   
   
   
7. AZARBARZIN A, Labarca G, Kwon Y, Wellman A, et al
   Physiologic Consequences of Upper Airway Obstruction in Sleep Apnea.
   Chest. 2024;166:1209-1217.
   PubMed     Abstract available
   
   
   October 2024
8. PATEL SR
   Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP.
   Chest. 2024;166:671-672.
   PubMed    
   
   
   
9. LAUNOIS C, Bailly S, Sabil A, Goupil F, et al
   Association Between Healthy Behaviors and Health Care Resource Use With Subsequent Positive Airway Pressure Therapy Adherence in OSA.
   Chest. 2024;166:845-856.
   PubMed     Abstract available
   
   
   
10. DHARMAKULASEELAN L, Boulos MI
    Sleep Apnea and Stroke: A Narrative Review.
    Chest. 2024;166:857-866.
    PubMed     Abstract available
    
    
    September 2024
11. PENDHARKAR SR, Kaambwa B, Kapur VK
    The Cost-Effectiveness of Sleep Apnea Management: A Critical Evaluation of the Impact of Therapy on Health Care Costs.
    Chest. 2024;166:612-621.
    PubMed     Abstract available
    
    
    August 2024
12. HORVATH CM, Fisser C, Floras JS, Sossalla S, et al
    Nocturnal Cardiac Arrhythmias in Heart Failure with Obstructive and Central Sleep Apnea.
    Chest. 2024 Aug 19:S0012-3692(24)04913-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    July 2024
13. EDWARDS BA, Joosten SA, Sands SA
    A Detailed Mechanistic Understanding of Positional and Nonpositional OSA: What Side Are You On?
    Chest. 2024;166:7-9.
    PubMed    
    
    
    
14. WANG X, Zhou T, Huang W, Zhang J, et al
    Differences in Physiologic Endotypes Between Nonpositional and Positional OSA: Results From the Shanghai Sleep Health Study Cohort.
    Chest. 2024;166:212-225.
    PubMed     Abstract available
    
    
    June 2024
15. YU JL, Plageman JM, Gouldman KP, Bliwise DL, et al
    Effects of Negative Pressure Ventilation on Lung Volume and Airflow in Drug-Induced Sleep Endoscopy.
    Chest. 2024;165:1534-1537.
    PubMed    
    
    
    May 2024
16. SHELGIKAR AV
    Sleep Education: A Narrative Review on Barriers and Opportunities to Grow a Diverse Sleep Team.
    Chest. 2024;165:1239-1246.
    PubMed     Abstract available
    
    
    
17. ALPERT N, Cole KV, Dexter RB, Sterling KL, et al
    Performance of Claims-Based Algorithms for Adherence to Positive Airway Pressure Therapy in Commercially Insured Patients With OSA.
    Chest. 2024;165:1228-1238.
    PubMed     Abstract available
    
    
    April 2024
18. QU XR, Han T, Li YM, Zhang XL, et al
    A 38-Year-Old Woman With REM Predominant Central Sleep Apnea After Bulbar Infarction.
    Chest. 2024;165:e101-e106.
    PubMed     Abstract available
    
    
    
19. AYAPPA I, Tolbert TM, Rapoport DM
    Flow Limitation Frequency: A Metric to Assess Consequences of OSA?
    Chest. 2024;165:769-770.
    PubMed    
    
    
    
20. STAYKOV E, Mann DL, Duce B, Kainulainen S, et al
    Increased Flow Limitation During Sleep Is Associated With Increased Psychomotor Vigilance Task Lapses in Individuals With Suspected OSA.
    Chest. 2024;165:990-1003.
    PubMed     Abstract available
    
    
    
21. LUCIANO YM, Porcacchia AS, Tufik S, Andersen ML, et al
    Prevalence and Incidence of Co-Morbid Insomnia and Sleep Apnea (Comisa) in Sao Paulo, Brazil.
    Chest. 2024;165:1004-1008.
    PubMed    
    
    
    
22. GRAZIANO S, Boldrini F, Pellicano GR, Milo F, et al
    Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults.
    Chest. 2024;165:800-809.
    PubMed     Abstract available
    
    
    March 2024
23. LABARCA G, Singh B
    Pitolisant: A Game Changer for Managing Sleepiness in OSA?
    Chest. 2024;165:486-487.
    PubMed    
    
    
    
24. PEPIN JL, Attali V, Causse C, Verbraecken J, et al
    Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA.
    Chest. 2024;165:692-703.
    PubMed     Abstract available
    
    
    
25. HOFF E, Strassberger C, Zou D, Grote L, et al
    Modification of Endotypic Traits in OSA by the Carbonic Anhydrase Inhibitor Sulthiame.
    Chest. 2024;165:704-715.
    PubMed     Abstract available
    
    
    February 2024
26. STANSBURY R, Billings ME
    Interpersonal Racism Contribution to Sleep Health Disparities: The Case of CPAP Adherence.
    Chest. 2024;165:246-247.
    PubMed    
    
    
    
27. WALLACE DM, Grant AB, Belisova-Gyure Z, Ebben M, et al
    Discrimination Predicts Suboptimal Adherence to CPAP Treatment and Mediates Black-White Differences in Use.
    Chest. 2024;165:437-445.
    PubMed     Abstract available
    
    
    January 2024
28. PEIXOTO DE MIRANDA EJF, Mazzotti DR, Santos RB, Souza SP, et al
    Incident Coronary Calcium Score in Patients With OSA With and Without Excessive Sleepiness: Brazilian Longitudinal Study of Adult Health.
    Chest. 2024;165:202-212.
    PubMed     Abstract available
    
    
    December 2023
29. GOMEZ-OLIVAS JD, Campos-Rodriguez F, Nagore E, Martorell A, et al
    Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients.
    Chest. 2023;164:1551-1559.
    PubMed     Abstract available
    
    
    November 2023
30. PENGO MF, Oscullo G, Gomez-Olivas JD, Bilo G, et al
    Nocturnal BP Profile Predicts CPAP Effect on BP in Patients With OSA and Resistant Hypertension.
    Chest. 2023;164:1302-1304.
    PubMed    
    
    
    
31. MYALL KJ, West AG, Martinovic JL, Lam JL, et al
    Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.
    Chest. 2023;164:1232-1242.
    PubMed     Abstract available
    
    
    October 2023
32. MARRIOTT RJ, Singh B, McArdle N, Darcey E, et al
    Does OSA Increase Risk for Cancer?: A Large Historical Sleep Clinic Cohort Study.
    Chest. 2023;164:1042-1056.
    PubMed     Abstract available
    
    
    
33. AURORA RN, Rooney MR, Wang D, Selvin E, et al
    Effects of Positive Airway Pressure Therapy on Glycemic Variability in Patients With Type 2 Diabetes and OSA: A Randomized Controlled Trial.
    Chest. 2023;164:1057-1067.
    PubMed     Abstract available
    
    
    September 2023
34. LANDRY SA, Mann DL, Beare R, McIntyre R, et al
    Oronasal vs Nasal Masks: The Impact of Mask Type on CPAP Requirement, Pharyngeal Critical Closing Pressure (P(crit)), and Upper Airway Cross-Sectional Areas in Patients With OSA.
    Chest. 2023;164:747-756.
    PubMed     Abstract available
    
    
    August 2023
35. JUN JC, Taylor SL
    Could Sleep Apnea Be Suffocating Your Gut Microbiome?
    Chest. 2023;164:290-291.
    PubMed    
    
    
    
36. LIM DC, Keenan BT
    Polysomnographic Subtypes and Incident Cancer: Another Adverse Outcome Related to Period Limb Movements.
    Chest. 2023;164:287-289.
    PubMed    
    
    
    
37. BALDANZI G, Sayols-Baixeras S, Theorell-Haglow J, Dekkers KF, et al
    OSA Is Associated With the Human Gut Microbiota Composition and Functional Potential in the Population-Based Swedish CardioPulmonary bioImage Study.
    Chest. 2023;164:503-516.
    PubMed     Abstract available
    
    
    
38. KENDZERSKA T, Murray BJ, Gershon AS, Povitz M, et al
    Polysomnographic Assessment of Sleep Disturbances in Cancer Development: A Historical Multicenter Clinical Cohort Study.
    Chest. 2023;164:517-530.
    PubMed     Abstract available
    
    
    July 2023
39. TURNBULL CD, Bailly S
    For One Night Only: Are Single-Night Studies Sufficient to Predict Risk of Hypertension in OSA?
    Chest. 2023;164:15-17.
    PubMed    
    
    
    June 2023
40. ALEXOPOULOS EI, Kaditis AG
    Intranasal Corticosteroids for Childhood OSA Syndrome: The Jury Is Still Out.
    Chest. 2023;163:e292.
    PubMed    
    
    
    
41. POWELL TA, Morris MJ, Holley A
    Does Untreated OSA Really Influence Exercise Tolerance?
    Chest. 2023;163:e288-e289.
    PubMed    
    
    
    
42. ALBRECHT JS, Kapur VK
    Untangling Treatment Effect From Patient Factors: The Challenge of the Use of Observational Studies to Investigate the Impact of Positive Airway Pressure Therapy on Medical Costs.
    Chest. 2023;163:1358-1359.
    PubMed    
    
    
    
43. KASI AS, Tapia IE
    Can Physiologic Biomarkers Predict Neurocognition in Congenital Central Hypoventilation Syndrome?
    Chest. 2023;163:1356-1357.
    PubMed    
    
    
    
44. AN J, Glick HA, Sawyer AM, Arguelles J, et al
    Association Between Positive Airway Pressure Adherence and Health Care Costs Among Individuals With OSA.
    Chest. 2023;163:1543-1554.
    PubMed     Abstract available
    
    
    
45. SLATTERY SM, Zelko FA, Vu EL, Dunne EC, et al
    Ventilatory and Orthostatic Challenges Reveal Biomarkers for Neurocognition in Children and Young Adults With Congenital Central Hypoventilation Syndrome.
    Chest. 2023;163:1555-1564.
    PubMed     Abstract available
    
    
    May 2023
46. TURNBULL CD, Thomas RJ
    Seeking Precision: Endotypes and Phenotypes of OSA.
    Chest. 2023;163:1016-1017.
    PubMed    
    
    
    
47. ROSSETTO A, Midelet A, Baillieul S, Tamisier R, et al
    Factors Associated With Residual Apnea-Hypopnea Index Variability During CPAP Treatment.
    Chest. 2023;163:1258-1265.
    PubMed     Abstract available
    
    
    
48. STRASSBERGER C, Hedner J, Sands SA, Tolbert TM, et al
    Night-to-Night Variability of Polysomnography-Derived Physiologic Endotypic Traits in Patients With Moderate to Severe OSA.
    Chest. 2023;163:1266-1278.
    PubMed     Abstract available
    
    
    
49. BOTTAZ-BOSSON G, Midelet A, Mendelson M, Borel JC, et al
    Remote Monitoring of Positive Airway Pressure Data: Challenges, Pitfalls, and Strategies to Consider for Optimal Data Science Applications.
    Chest. 2023;163:1279-1291.
    PubMed     Abstract available
    
    
    April 2023
50. GENTA PR, Taranto-Montemurro L
    Task Accomplished: Promising Effects of a New Topical Potassium Channel Antagonist in OSA.
    Chest. 2023;163:749-750.
    PubMed    
    
    
    
51. LUTSEY PL, Zineldin I, Misialek JR, Full KM, et al
    OSA and Subsequent Risk of Hospitalization With Pneumonia, Respiratory Infection, and Total Infection: The Atherosclerosis Risk in Communities Study.
    Chest. 2023;163:942-952.
    PubMed     Abstract available
    
    
    
52. OSMAN AM, Mukherjee S, Altree TJ, Delbeck M, et al
    Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility: A Translational, Placebo-Controlled Trial.
    Chest. 2023;163:953-965.
    PubMed     Abstract available
    
    
    March 2023
53. RAJVANSHI N, Prabhakaran K, Kumar P, Goyal JP, et al
    A Trial of Intranasal Corticosteroids to Treat Childhood OSA Syndrome: Is It Ineffective?
    Chest. 2023;163:e149.
    PubMed    
    
    
    
54. PUNJABI NM, Brown TT, Aurora RN, Patel SR, et al
    Prevalence and Predictors of Sleep-Disordered Breathing in Men Participating in the Multicenter AIDS Cohort Study.
    Chest. 2023;163:687-696.
    PubMed     Abstract available
    
    
    February 2023
55. HAO W, Wang X, Fan J, Guo R, et al
    Prognostic Implications of Obstructive Sleep Apnea in Acute Coronary Syndrome by Obesity Status.
    Chest. 2023 Feb 8:S0012-3692(23)00173-3. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available
    
    
    January 2023
56. LECHAT B, Nguyen DP, Reynolds A, Loffler K, et al
    Single night diagnosis of sleep apnea contributes to inconsistent cardiovascular outcome findings.
    Chest. 2023 Jan 27:S0012-3692(23)00157-5. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge.